Bridgeway Capital Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-70,611
| Closed | -$508K | – | 1477 |
|
|
2022
Q3 | $508K | Sell |
70,611
-25,000
| -26% | -$180K | 0.01% | 891 |
|
|
2022
Q2 | $814K | Sell |
95,611
-50,000
| -34% | -$426K | 0.02% | 773 |
|
|
2022
Q1 | $1.31M | Hold |
145,611
| – | – | 0.03% | 717 |
|
|
2021
Q4 | $2.02M | Sell |
145,611
-8,000
| -5% | -$111K | 0.04% | 612 |
|
|
2021
Q3 | $1.64M | Hold |
153,611
| – | – | 0.03% | 696 |
|
|
2021
Q2 | $1.38M | Buy |
+153,611
| New | +$1.38M | 0.02% | 747 |
|
|
2019
Q2 | – | Sell |
-35,750
| Closed | -$245K | – | 1408 |
|
|
2019
Q1 | $245K | Hold |
35,750
| – | – | ﹤0.01% | 1195 |
|
|
2018
Q4 | $132K | Sell |
35,750
-3,000
| -8% | -$11.1K | ﹤0.01% | 1270 |
|
|
2018
Q3 | $245K | Hold |
38,750
| – | – | ﹤0.01% | 1286 |
|
|
2018
Q2 | $293K | Hold |
38,750
| – | – | ﹤0.01% | 1252 |
|
|
2018
Q1 | $310K | Hold |
38,750
| – | – | ﹤0.01% | 1196 |
|
|
2017
Q4 | $434K | Buy |
38,750
+20,000
| +107% | +$224K | ﹤0.01% | 1139 |
|
|
2017
Q3 | $218K | Buy |
+18,750
| New | +$218K | ﹤0.01% | 1267 |
|
|
2017
Q2 | – | Sell |
-18,750
| Closed | -$219K | – | 1481 |
|
|
2017
Q1 | $219K | Hold |
18,750
| – | – | ﹤0.01% | 1257 |
|
|
2016
Q4 | $168K | Hold |
18,750
| – | – | ﹤0.01% | 1334 |
|
|
2016
Q3 | $610K | Hold |
18,750
| – | – | 0.01% | 996 |
|
|
2016
Q2 | $345K | Hold |
18,750
| – | – | 0.01% | 1186 |
|
|
2016
Q1 | $313K | Buy |
+18,750
| New | +$313K | 0.01% | 1202 |
|